Clinical Trials
3
Active:0
Completed:1
Trial Phases
3 Phases
Phase 2:1
Phase 3:1
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (33.3%)Phase 2
1 (33.3%)Phase 3
1 (33.3%)Effects of Continued Administration of Empagliflozin in Patients With Heart Failure on Active SGLT2 Inhibitor Treatment Admitted for Acute Decompensated Heart Failure
Phase 3
Not yet recruiting
- Conditions
- Acute Decompensated Heart Failure (ADHF)
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-06-26
- Last Posted Date
- 2025-07-04
- Lead Sponsor
- Christian Schulze
- Target Recruit Count
- 556
- Registration Number
- NCT07038356
ECMOsorb Trial - Impact of a VA-ECMO in Combination with CytoSorb in Critically Ill Patients with Cardiogenic Shock
Not Applicable
Recruiting
- Conditions
- Cardiogenic Shock
- First Posted Date
- 2021-08-30
- Last Posted Date
- 2025-03-24
- Lead Sponsor
- Christian Schulze
- Target Recruit Count
- 54
- Registration Number
- NCT05027529
- Locations
- 🇩🇪
Jena University Hospital, Department of Cardiology, Jena, Thuringia, Germany
Effects of Empagliflozin on Diuresis and Renal Function in Patients With Acute Decompensated Heart Failure
Phase 2
Completed
- Conditions
- Acute Decompensated Heart Failure
- Interventions
- Drug: Placebo
- First Posted Date
- 2019-08-07
- Last Posted Date
- 2021-08-03
- Lead Sponsor
- Christian Schulze
- Target Recruit Count
- 60
- Registration Number
- NCT04049045
- Locations
- 🇩🇪
Department of Internal Medicine I, Jena University Hospital, Jena, Germany
News
No news found